✨ Free AI Report
Ipca Laboratories Limited: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Ipca Laboratories Limited
Company Research

Ipca Laboratories Limited: Business Overview, Financials & Competitive Analysis

Ipca Laboratories Limited scores 7/10 on the AskCyborg Cyborg Score (Strong). Vertically integrated pharmaceutical exporter with capacity expansion momentum and favorable API demand dynamics, though valuation appears stretched relative to profitability metrics. Ipca demonstrates solid fundamentals with 14% five-year revenue growth outpacing industry averages, strong Q2 FY26 API segment growth of 28%, and strategic capacity expansion. However, concerns include a.

What is Ipca Laboratories Limited's industry? Ipca Laboratories Limited (ipca.com) operates in Pharmaceuticals - Drug Manufacturers (Specialty & Generic). AskCyborg classifies Ipca Laboratories Limited under Pharmaceuticals - Drug Manufacturers (Specialty & Generic) in its company registry.

Ipca Laboratories is a fully integrated Indian pharmaceutical company founded in 1949, manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) across diverse the...

7/ 10Strong

Cyborg Score thesis

Vertically integrated pharmaceutical exporter with capacity expansion momentum and favorable API demand dynamics, though...

Read the full analyst-debate transcript →
Industry Pharmaceuticals - Drug Manufacturers (Specialty & Generic)
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Ipca Laboratories Limited Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Ipca Laboratories Limited

AskCyborg analysts argue the bull and bear cases for Ipca Laboratories Limited across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Ipca Laboratories Limited OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Ipca Laboratories Limited Overview

Pro stress-test →

Ipca Laboratories is a fully integrated Indian pharmaceutical company founded in 1949, manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) across diverse therapeutic segments. The company operates globally, exporting to over 100 countries while maintaining 18 manufacturing units in India, positioning itself as one of India's top 20 pharmaceutical companies.

Strategic Profile

Pro stress-test →

Ipca's competitive advantage lies in its backward-integrated operations focused on supply chain reliability and cost competitiveness, with nearly 79% of API exports serving international markets. The company is diversified across multiple therapeutic areas including cardiology, malaria, diabetes, and anti-malarial segments, with recent expansion through strategic acquisitions and a new ₹182 crore API manufacturing facility that commenced production in February 2026.

Competitive Landscape

Pro stress-test →

Ipca operates in India's fragmented pharmaceutical market dominated by players like Cipla, Dr. Reddy's, Aurobindo, and Sun Pharma. The company differentiates through integrated operations (both APIs and formulations), strong API export capability, and therapeutic segment diversification. While competing in high-volume generic segments, Ipca's backward integration provides cost and supply chain advantages.

Industry Context

Ipca Laboratories Limited operates in Pharmaceuticals - Drug Manufacturers (Specialty & Generic).

Key facts

Founded: 1949 · Headquarters: Mumbai, India · Employees: 16,778 · Revenue: ₹2,556.50 crore (Q2 FY26) · Market cap: ₹36,589 crore

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Ipca Laboratories Limited.

  • Q2 FY26 showed API segment surge of 28% driven by strong international performance, with consolidated EBITDA margin guidance raised to over 20%
  • New ₹182 crore greenfield API facility at Hingani, Wardha commenced commercial production February 9, 2026, enhancing capacity and competitiveness
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026New API/intermediates manufacturing facility at Hingani, Wardha commenced commercial production with ₹182 crore investment
  • February 2026Tarapur API facility FDA inspection (December 2025) resulted in VAI classification indicating minimally acceptable CGMP standards
  • +1 moreTrack every material event for Ipca Laboratories Limited as it happens. Explore monitoring →
Get alerted when Ipca Laboratories Limited has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

CiplaIntegrated pharma with global presence→AurobindoDiversified API and formulation manufacturer→Sun PharmaLarge-cap pharma with specialty focus→Dr. Reddy'sResearch-led integrated pharmaceutical company→

Compare Ipca Laboratories Limited with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Ipca Laboratories Limited operates in Pharmaceuticals - Drug Manufacturers (Specialty & Generic). See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals - Drug Manufacturers (Specialty & Generic) research →
NEW · MCP server

Ask your AI assistant about Ipca Laboratories Limited

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Ipca Laboratories Limited and its top competitor on Cyborg Score”
“What did Ipca Laboratories Limited do this quarter?”
“Is Ipca Laboratories Limited a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Ipca Laboratories Limited do?+
Ipca Laboratories is a fully integrated Indian pharmaceutical company founded in 1949, manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) across diverse the...
What is Ipca Laboratories Limited's Cyborg Score?+
Ipca Laboratories Limited has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Ipca Laboratories Limited's main competitors?+
Named competitors include Cipla, Aurobindo, Sun Pharma, Dr. Reddy's. The full competitive landscape is in the AskCyborg report.
How can I get the full Ipca Laboratories Limited research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Ipca Laboratories Limited research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Ipca Laboratories Limited over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Pharmaceuticals - Drug Manufacturers (Specialty & Generic) research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7RPG Life Sciences Limited7Cipla Limited